Skip to content

Predisposing Factors Associated With Chemotherapy Toxicity in Elderly Cancer Patients

Predisposing Factors Associated With Chemotherapy Toxicity in Elderly Cancer Patients: A Prospective Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02317757
Enrollment
150
Registered
2014-12-16
Start date
2015-01-31
Completion date
2016-12-31
Last updated
2016-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

elderly cancer patients, chemotherapy toxicity

Brief summary

These days, there is higher proportion of elderly cancer patients. Most of them have comorbidities, borderline performance status and nutritional status. The discontinuation of chemotherapy due to unbearable toxicities was not uncommon. Comprehensive geriatric assessment might be beneficial in selection of suitable elderly patients for chemotherapy administration.

Detailed description

The patients with the age more than 70 years old who scheduled for chemotherapy were enrolled. Geriatric assessment was performed before starting chemotherapy. The toxicity will be recorded prospectively. Predisposing factors of grade 3 and 4 toxicity will be reported.

Interventions

None listed

Sponsors

Mahidol University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* more than 70 years of age * plan to receive first cycle of chemotherapy * histologically or cytologically proved of cancer

Exclusion criteria

* patients who have concurrent chemoradiotherapy * patients who received local chemotherapy

Design outcomes

Primary

MeasureTime frame
predisposing factors of patients developed grade 3 or 4 chemotherapy toxicityfrom starting chemotherapy to 1 month after last dose of chemotherapy

Secondary

MeasureTime frame
incidence of grade 3 or 4 chemotherapy toxicity in elderlyfrom starting chemotherapy to 1 month after last dose of chemotherapy
Factors associated with good quality of life during receiving chemotherapyfrom starting chemotherapy to 1 month after last dose of chemotherapy

Countries

Thailand

Contacts

Primary ContactSuthinee Ithimakin, MD
Aesi105@yahoo.co.th66898127440

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026